Paola Soliveri1,2, Dominga Paridi3,4, Francesca Del Sorbo3,5, Irene Tramacere6, Floriano Girotti3,7. 1. Parkinson and Movement Disorders Unit, IRCCS Foundation Carlo Besta Neurological Institute, Via Celoria 11, 20133, Milan, Italy. paola.soliveri@asst-pini-cto.it. 2. Parkinson Institute, ASST Gaetano Pini-CTO, Via Bignami 1, 20126, Milan, Italy. paola.soliveri@asst-pini-cto.it. 3. Parkinson and Movement Disorders Unit, IRCCS Foundation Carlo Besta Neurological Institute, Via Celoria 11, 20133, Milan, Italy. 4. Fondazione Grigioni per il Morbo di Parkinson, Via Bignami 1, 20126, Milan, Italy. 5. Parkinson Institute, ASST Gaetano Pini-CTO, Via Bignami 1, 20126, Milan, Italy. 6. Department of Research and Clinical Development, Scientific Directorate, IRCCS Foundation Carlo Besta Neurological Institute, Via Celoria 11, 20133, Milan, Italy. 7. Department of Neurology and Laboratory of Neuroscience, San Luca IRCCS Auxological Institute, Piazzale Brescia 20, 20149, Milan, Italy.
Abstract
BACKGROUND: Apathy is the commonest psychiatric manifestation in Huntington's disease (HD). We investigated negative psychiatric symptoms-as determined by the Scale for the Assessment of Negative Psychiatric Symptoms (SANS)-in early and intermediate HD patients, hypothesizing that such symptoms would be prominent and constitute a more comprehensive and clinically relevant assessment than apathy alone. We also assessed relations between negative symptoms and disease stage, mood, motor, and cognitive disturbances. METHODS: Thirty-five stage 1 and twenty-nine stage 2 consecutive adult HD outpatients were administered SANS; the Scale for the Assessment of Positive Psychiatric Symptoms (SAPS); the motor section of the Unified Huntington's Disease Rating Scale (UHDRS); Total Functional Capacity (TFC); and instruments to assess cognition, anxiety, and depression. RESULTS: The groups had similar age, education, and CAG length. Scores on the Hamilton depression and anxiety scales, and SAPS were similar. Negative symptoms were pervasive in the entire series. Illness duration, UHDRS, TFC, cognition, and SANS scores were significantly worse in stage 2. Mini Mental State Examination (MMSE) and SAPS scores were significantly (multiple regression) associated with SANS score, while Hamilton depression and UHDRS scores were not. SANS score was also associated with stage after removing the cognition-related domains of alogia and attention. CONCLUSIONS: Negative symptoms are pervasive in HD but more severe in stage 2. The associations of SANS with MMSE and SAPS suggest impaired cognition and thinking as important in generating negative symptoms. SANS appears useful for revealing a wide range of negative symptoms in HD.
BACKGROUND: Apathy is the commonest psychiatric manifestation in Huntington's disease (HD). We investigated negative psychiatric symptoms-as determined by the Scale for the Assessment of Negative Psychiatric Symptoms (SANS)-in early and intermediate HD patients, hypothesizing that such symptoms would be prominent and constitute a more comprehensive and clinically relevant assessment than apathy alone. We also assessed relations between negative symptoms and disease stage, mood, motor, and cognitive disturbances. METHODS: Thirty-five stage 1 and twenty-nine stage 2 consecutive adult HD outpatients were administered SANS; the Scale for the Assessment of Positive Psychiatric Symptoms (SAPS); the motor section of the Unified Huntington's Disease Rating Scale (UHDRS); Total Functional Capacity (TFC); and instruments to assess cognition, anxiety, and depression. RESULTS: The groups had similar age, education, and CAG length. Scores on the Hamilton depression and anxiety scales, and SAPS were similar. Negative symptoms were pervasive in the entire series. Illness duration, UHDRS, TFC, cognition, and SANS scores were significantly worse in stage 2. Mini Mental State Examination (MMSE) and SAPS scores were significantly (multiple regression) associated with SANS score, while Hamilton depression and UHDRS scores were not. SANS score was also associated with stage after removing the cognition-related domains of alogia and attention. CONCLUSIONS: Negative symptoms are pervasive in HD but more severe in stage 2. The associations of SANS with MMSE and SAPS suggest impaired cognition and thinking as important in generating negative symptoms. SANS appears useful for revealing a wide range of negative symptoms in HD.
Authors: Saul Martinez-Horta; Jesus Perez-Perez; Erik van Duijn; Ramon Fernandez-Bobadilla; Mar Carceller; Javier Pagonabarraga; Berta Pascual-Sedano; Antonia Campolongo; Jesus Ruiz-Idiago; Frederic Sampedro; G Bernhard Landwehrmeyer; Jaime Kulisevsky Journal: Parkinsonism Relat Disord Date: 2016-02-11 Impact factor: 4.891
Authors: P Robert; K L Lanctôt; L Agüera-Ortiz; P Aalten; F Bremond; M Defrancesco; C Hanon; R David; B Dubois; K Dujardin; M Husain; A König; R Levy; V Mantua; D Meulien; D Miller; H J Moebius; J Rasmussen; G Robert; M Ruthirakuhan; F Stella; J Yesavage; R Zeghari; V Manera Journal: Eur Psychiatry Date: 2018-08-17 Impact factor: 5.361
Authors: P Robert; C U Onyike; A F G Leentjens; K Dujardin; P Aalten; S Starkstein; F R J Verhey; J Yessavage; J P Clement; D Drapier; F Bayle; M Benoit; P Boyer; P M Lorca; F Thibaut; S Gauthier; G Grossberg; B Vellas; J Byrne Journal: Eur Psychiatry Date: 2009-02-07 Impact factor: 5.361
Authors: Erik van Duijn; David Craufurd; Anna A M Hubers; Erik J Giltay; Raphael Bonelli; Hugh Rickards; Karen E Anderson; Marleen R van Walsem; Rose C van der Mast; Michael Orth; G Bernhard Landwehrmeyer Journal: J Neurol Neurosurg Psychiatry Date: 2014-05-14 Impact factor: 10.154
Authors: Danielle A Schlosser; Timothy R Campellone; Bruno Biagianti; Kevin L Delucchi; David E Gard; Daniel Fulford; Barbara K Stuart; Melissa Fisher; Rachel L Loewy; Sophia Vinogradov Journal: Schizophr Res Date: 2015-10-31 Impact factor: 4.939